Financial results - YAKYS BIOMED S.R.L.

Financial Summary - Yakys Biomed S.r.l.
Unique identification code: 38549260
Registration number: J15/1569/2017
Nace: 4778
Sales - Ron
87.289
Net Profit - Ron
1.136
Employee
3
The most important financial indicators for the company Yakys Biomed S.r.l. - Unique Identification Number 38549260: sales in 2023 was 87.289 euro, registering a net profit of 1.136 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al altor bunuri noi, in magazine specializate having the NACE code 4778.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Yakys Biomed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 438 22.630 91.737 102.772 92.513 87.289
Total Income - EUR - - - - 1.312 24.861 98.597 102.774 104.122 92.293
Total Expenses - EUR - - - - 2.462 25.514 94.685 100.732 102.987 90.274
Gross Profit/Loss - EUR - - - - -1.149 -653 3.912 2.042 1.135 2.019
Net Profit/Loss - EUR - - - - -1.162 -909 3.178 1.415 92 1.136
Employees - - - - 1 1 1 2 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -5.4%, from 92.513 euro in the year 2022, to 87.289 euro in 2023. The Net Profit increased by 1.044 euro, from 92 euro in 2022, to 1.136 in the last year.

Check the financial reports for the company - Yakys Biomed S.r.l.

Rating financiar

Financial Rating -
Yakys Biomed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Yakys Biomed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Yakys Biomed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Yakys Biomed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Yakys Biomed S.r.l. - CUI 38549260

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 124 122 157 0 0 804
Current Assets - - - - 4.572 7.191 24.569 17.515 16.716 22.378
Inventories - - - - 4.438 7.059 21.358 16.878 14.912 18.876
Receivables - - - - 0 0 2.720 378 378 164
Cash - - - - 134 132 491 258 1.426 3.338
Shareholders Funds - - - - -1.119 -2.006 1.210 2.598 2.699 3.827
Social Capital - - - - 43 42 41 40 41 40
Debts - - - - 5.815 9.319 23.517 14.917 14.016 19.355
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4778 - 4778"
CAEN Financial Year 4778
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 22.378 euro in 2023 which includes Inventories of 18.876 euro, Receivables of 164 euro and cash availability of 3.338 euro.
The company's Equity was valued at 3.827 euro, while total Liabilities amounted to 19.355 euro. Equity increased by 1.136 euro, from 2.699 euro in 2022, to 3.827 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Yakys Biomed S.r.l.

Comments - Yakys Biomed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.